Kanghong Investigative Site — Midland, Texas

Kanghong Investigative Site is a clinical research site located in Midland, Texas, United States 79706.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Kanghong Investigative Site has participated in 1 clinical trials.

Therapeutic areas: Neovascular Age-related Macular Degeneration.

Sponsors: Chengdu Kanghong Biotech Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Midland

Browse all research sites in Texas · View every site in Midland

• Ohio State University Telemedicine
• Allison Cancer Center
• GSK Investigational Site
• Novo Nordisk Investigational Site
• Diabetes Center of the Southwest
• Texas Oncology-Midland Allison Cancer Center
• Pfizer Investigational Site
• Midland Clinical Research Center
• Research Site
• Local Institution
• Texas Oncology - West Texas
• Premiere Retina Specialists

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kanghong Investigative Site?

Kanghong Investigative Site has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kanghong Investigative Site conducted?

Kanghong Investigative Site has 1 clinical trials on record. Their work covers Neovascular Age-related Macular Degeneration.

Is Kanghong Investigative Site accredited by Crixeo Clinical Trials?

Kanghong Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kanghong Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.